Janet D. Siliciano

Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control

Decoding heterogeneous single-cell perturbation responses

Factors associated with resistance of HIV-1 reservoir viruses to neutralization by autologous IgG antibodies

Proviruses in CD4 ⁺ T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremia

SIV proviruses seeded later in infection are harbored in short-lived CD4+ T cells

Superinfection promotes replication and diversification of defective HIV-1 proviruses in people with non-suppressible viraemia

Identifying correlates of viral rebound timing and viral control in SHIV-infected infant macaques after ART interruption

Mild HIV-specific selective forces overlaying natural CD4+ T cell dynamics explain the clonality and decay dynamics of HIV reservoir cells

Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells

Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques

HIV cure: The daunting scale of the problem

CD4+ T cells with latent HIV-1 have reduced proliferative responses to T cell receptor stimulation

Cognate antigen engagement induces HIV-1 expression in latently infected CD4+ T cells from people on long-term antiretroviral therapy

The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy

Clonally expanded HIV-1 proviruses with 5′-leader defects can give rise to nonsuppressible residual viremia

Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variants

Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques

A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design

Measuring the latent reservoir for HIV-1: Quantification bias in near full-length genome sequencing methods

Genome-wide CRISPR screens identify combinations of candidate latency reversing agents for targeting the latent HIV-1 reservoir

Engaging innate immunity in HIV-1 cure strategies

In Vivo Dynamics of the Latent Reservoir for HIV-1: New Insights and Implications for Cure

Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption

Impact of Anti–PD-1 and Anti–CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study

Distinct viral reservoirs in individuals with spontaneous control of HIV-1

Differential decay of intact and defective proviral DNA in HIV-1–infected individuals on suppressive antiretroviral therapy

Antigen-driven clonal selection shapes the persistence of HIV-1–infected CD4+ T cells in vivo

Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy

Recommendations for measuring HIV reservoir size in cure-directed clinical trials

Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA